Memorial Sloan Kettering Cancer Center (MSK) is bringing artificial intelligence into two important areas of cancer care, with new work focused on clinical trial matching and predicting immunotherapy response using routine blood tests. For patients from the Middle East who travel abroad for specialist cancer treatment, they point to more informed treatment decisions and a ... The post New MSK initiatives bring AI into everyday cancer care appeared first on The Gulf Time Newspaper.